Back
Cinemark Holdings Vs. Akero Therapeutics Industry Stock Comparison
Sell
27
CNK
Cinemark Holdings
Last Price:
16.38
Seasonality Move:
-5.3%
Buy
53
AKRO
Akero Therapeutics
Last Price:
45.34
Seasonality Move:
18.98%
Sell
27
Cinemark Holdings (CNK)
is a Sell
Is Cinemark Holdings a Buy, Sell or Hold?
- The current Cinemark Holdings [CNK] share price is $16.01. The Score for CNK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- CNK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $44.58. The Score for AKRO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNK Stock Price Chart
What is Cinemark Holdings's stock price today?
-
The Cinemark Holdings share price today is $16.01
The current trend is moderately bearish and CNK is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $44.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
CNK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 43.51 | Sell |
| Chaikin Money Flow: | 1479252 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.3 - 17.02) | Sell |
| Bollinger Bands (100): | (11.7 - 16.28) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 50.12 | Buy |
| Chaikin Money Flow: | 126894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.03 - 46.67) | Sell |
| Bollinger Bands (100): | (40.37 - 47.59) | Buy |
CNK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.66 | Sell |
| 20-day SMA: | 16.66 | Sell |
| 50-day SMA: | 15.92 | Buy |
| 200-day SMA: | 13.07 | Buy |
| 8-day EMA: | 16.51 | Sell |
| 20-day EMA: | 16.56 | Sell |
| 50-day EMA: | 15.81 | Buy |
| 200-day EMA: | 14.26 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.59 | Sell |
| 20-day SMA: | 45.6 | Sell |
| 50-day SMA: | 42.38 | Buy |
| 200-day SMA: | 39.35 | Buy |
| 8-day EMA: | 44.66 | Sell |
| 20-day EMA: | 44.8 | Sell |
| 50-day EMA: | 43.93 | Buy |
| 200-day EMA: | 38.46 | Buy |
Cinemark Holdings Earnings Growth & CNK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.28 per share, an increase this year of $2.33 per share, and an increase next year of $0.56 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.76 per share.
Cinemark Holdings Technical Analysis
| May-17 | May-18 | May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May-17 | May-18 | May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||